ViAqua Therapeutics Ltd.
viaqua-t.com
Farming & Agriculture
Seafood
Aquaculture
As featured in
Claim pageClaim
Follow
Overview
News
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Total raised
$12.6M
2 rounds on record
Latest round
$8.3M
Venture round · Sep 2023 · 3 yr ago
Team
11-50
employees, estimated range
Backers
2
S2G Investments, The Trendlines Group
The money's age
Long since its last round
37 months since the last round · not hiring
Momentum
0/100
no fresh signals
Last sign of life
this month
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Sep 5, 2023
Raised a round Venture round $8.3M · led by S2G Investments · menafn
Jun 8, 2021
Raised a round Venture round $4.3M · led by S2G Investments
2017
Founded
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Venture round | Sep 2023 | $8.3M | S2G Investments lead | menafn |
| Venture round | Jun 2021 | $4.3M | S2G Investments lead | viaqua-t.com |
Backed byfrom the funds' portfolios and accelerator catalogs
S2G Investments 
The Trendlines Group Overview
ViAqua is developing the first orally administered treatment in aquaculture to stop diseases from developing and to prevent viral epidemics.
News
Exploring Uncharted Waters The Impact of iRNA Sequences on Shark Stem Cells in Recent Trials
In an exciting new study, researchers are diving into the intersection of biotechnology and marine biology by examining how interfering...
Read more
Report
Economic Implications of Disease Prevention Strategies in Aquaculture: An Emerging Perspective
Aquaculture, the practice of farming fish and shellfish, is crucial for ensuring global food security and economic stability. In this...
Read more
Report
Unveiling Trends in Aquaculture Diseases: An Editorial Examination of Hypothetical Research Insights
Aquaculture has become a vital part of our global food system. However, as fish farming expands, it faces significant risks from various...
Read more
Report
Innovative Approaches to Oyster Disease Control: Insights from a Fictional Research Study
A high angle view of a fictional graph depicting trends in oyster disease control. This fictional study not only inspires future research...
Read more
Report
Exploring the Paradox of Seafood Popularity Amid Global Food Scarcity Trends
In recent years, seafood has surged in popularity, becoming a staple in diets across the globe. This boom has sparked important conversations about its consequences amidst the ongoing struggle with food scarcity. As the world's population continues to gro
Read more
Report
ViAqua Therapeutics: $8.25 Million Closed To Improve Animal Health In Aquaculture
ViAqua Therapeutics - a biotechnology company and developer of an orally administered RNA-particle platform to promote and improve animal health in aquaculture - recently announced it has completed a US$8.25 million round led by S2G Ventures with particip
Read more
Report
ViAqua Therapeutics Announces $8.25M Investment Led by S2G Ventures to Scale RNA-Based Solutions in Aquaculture
HAIFA, Israel, Sept. 5, 2023 /PRNewswire/ -- ViAqua Therapeutics, a biotechnology company and developer of an orally administered...
Read more
Report
ViAqua Therapeutics Announces $8.25M Investment Led by S2G Ventures to Scale RNA-Based Solutions in Aquaculture
/PRNewswire/ -- ViAqua Therapeutics, a biotechnology company and developer of an orally administered RNA-particle platform to promote and improve animal health...
Read more
Report
ViAqua Therapeutics Announces $8.25M Investment Led by S2G Ventures to Scale RNA-Based Solutions in Aquaculture
/PRNewswire/ -- ViAqua Therapeutics, a biotechnology company and developer of an orally administered RNA-particle platform to promote and improve animal health...
Read more
Report
Viaqua Therapeutics Announces $8.25M Investment Led By S2g Ventures To Scale Rna-Based Solutions In Aquaculture
Viaqua Therapeutics Announces $8.25M Investment Led By S2g Ventures To Scale Rna-Based Solutions In Aquaculture.Funding will enable ViAqua to bring its first product to market, invest in R&D for future products, and prove the platform
Read more
Report
Show more news